// App-Quantinova.ai

S1001 2015 AHA : New Insights into the Mechanisms of Sepsis: The Role of Proprotein Convertase Subtilisin/kexin Type 9 as a Key Regulator of Pathogen Toxin Clearance

Researchers

Presenter

  • Yingjin Wang

Principal Investigators

  • John Boyd

  • Keith R Walley

Medical Centers

  • The University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Sepsis

Biomarkers

  • Proprotein convertase subtilisin/kexin type 9

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved